(Q34804827)

4 August 2017

1 reference

title

Immunomodulating activities of soluble synthetic polymer-bound drugs (English)

1 reference

4 August 2017

Blanka Ríhová

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

Advanced Drug Delivery Reviews

4 August 2017

published in

1 reference

4 August 2017

volume

54

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

653-674

1 reference

Immunogenicity of N-(2-hydroxypropyl)-methacrylamide copolymers--potential hapten or drug carriers

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Effect of the chemical structure of N-(2-hydroxypropyl)methacrylamide copolymers on their ability to induce antibody formation in inbred strains of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

10 years of patch testing with the (meth)acrylate series

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Cross-reactivity patterns of contact-sensitizing methacrylates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Preparation and properties of polyethylene glycol-trypsin adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Efficient mobilization of haematopoietic progenitors after a single injection of pegylated recombinant human granulocyte colony-stimulating factor in mouse strains with distinct marrow-cell pool sizes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Thrombopoietin therapy increases platelet yields in healthy platelet donors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Phase I-II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Phase I trial of pegylated liposomal doxorubicin and docetaxel in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Synthesis and application of a poly(ethylene glycol)-antibody affinity ligand for cell separations in aqueous polymer two-phase systems

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Physicochemical and biological properties of poly(ethylene glycol)-coupled immunoglobulin G. Part II. Effect of molecular weight of poly(ethylene glycol).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Conjugation of Cu,Zn-superoxide dismutase with succinylated gelatin: pharmacological activity and cell-lubricating function

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Acquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Immunopotentiation and delivery systems for antigens for single-step immunization: recent trends and progress

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Oral immunization with poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres containing pneumotropic bacterial antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Polymeric nanoparticles as delivery system for influenza virus glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Oral immunization with Helicobacter pylori-loaded poly(D, L-lactide-co-glycolide) nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Characterization of mucoadhesive microspheres for the induction of mucosal and systemic immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

A single-step immunization by sustained antigen release

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Single-step immunization using a controlled release, biodegradable polymer with sustained adjuvant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Nonionic triblock copolymers facilitate delivery of exogenous proteins into the MHC class I and class II processing pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Adjuvant activity of non-ionic block copolymers. IV. Effect of molecular weight and formulation on titre and isotype of antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Mucosal immunity and vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Alkyl-polyacrylate esters are strong mucosal adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Intranasal administration of HIV-DNA vaccine formulated with a polymer, carboxymethylcellulose, augments mucosal antibody production and cell-mediated immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Poly(butyl-2-cyanoacrylate) particles as adjuvants for oral immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Microparticles as potentially orally active immunological adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

1 reference

7 January 2021

Induction of Circulating Interferon by Synthetic Anionic Polymers of Known Composition

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Antiviral activity of polyacrylic and polymethacrylic acids. II. Mode of action in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Interferon: an inducer of macrophage activation by polyanions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Enzymatic degradation and immunogenic properties of derivatized dextrans

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Nuclear phospholipids in human lymphocytes activated by phytohemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Boronate-containing polymer as novel mitogen for lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Drug-polymer conjugates: potential for improved chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Immunomodulation by antibacterial agents. Is it clinically relevant?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Immunostimulating agents: what next? A review of their present and potential medical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Antibody-directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

The influence of cytotoxicity of macromolecules and of VEGF gene modulated vascular permeability on the enhanced permeability and retention effect in resistant solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Time- and concentration-dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Differences in the intracellular fate of free and polymer-bound doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

The role of APO-1-mediated apoptosis in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

The Fas counterattack: cancer as a site of immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Apoptosis by death factor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab')(2)-targeted conjugates and combined therapy with immunomodulators

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

The biology of human natural killer-cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Development of hyporesponsiveness of natural killer cells to augmentation of activity after multiple treatments with biological response modifiers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Augmentation of natural cell activity in tumor-bearing and normal mice by MVE-2

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Interferon induction in man by a synthetic polyanion of defined composition

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Measurement of modulation of mouse complement levels in vivo, utilizing a microtiter hemolytic assay

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Bimodal effects of MVE-2 on cytotoxic activity of natural killer cell and macrophage tumoricidal activities

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Conjugation of poly(styrene-co-maleic acid) derivatives to the antitumor protein neocarzinostatin: pronounced improvements in pharmacological properties

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Immunomodulating activities of orally administered SMANCS, a polymer-conjugated derivative of the proteinaceous antibiotic neocarzinostatin, in an oily formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Changes in the host natural killer cell population in mice during tumor development. 2. The mechanism of suppression of NK activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Biosynthesis of the Collagen-like C1q Molecule and its Receptor Functions for Fc and Polyanionic Molecules on Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Selective inhibition of human natural killing and antibody-dependent cellular cytotoxicity by a polyanion

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Therapy of peritoneal murine cancer with biological response modifiers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Metabolic and morphological observations on the effect of surface-active agents of leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Relationship between glycolysis and respiration in surfactant-treated leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Stimulation of macrophage by polyanions and its conjugated proteins and effect on cell membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

Lack of correlation between antitumour response and serum interferon levels in mice treated with SSM, an immunotherapeutic anticancer agent

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900043-1

7 January 2021

10.1016/S0169-409X(02)00043-1

Identifiers

DOI

1 reference

4 August 2017

1 reference